Scientists have discovered a new way to predict which cancer tumours will become aggressive before they spread – paving the way for treatments to stop the disease in its tracks.A new study, published ...

Triple-negative breast cancer (TNBC) is an aggressive form of the disease that accounts for 15% of all breast cancer cases.

GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Miguel Muniz discussing outcomes for 177 Lu-PSMA-617 with and without concurrent use of androgen receptor pathway ...

Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: ...

(UroToday.com) The 2025 GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Ivan de Kouchkovsky discussing the impact of baseline PSMA PET in patients with metastatic ...

Fresh snow has arrived just in time for the Fresh Tracks 5K Snowshoe event, raising funds for metastatic breast cancer ...

Dutch health insurers have stopped fully covering two of three medicines for metastatic hormonal breast cancer. Since January ...

Padcev plus Keytruda was found to maintain benefit over chemotherapy in untreated locally advanced or metastatic urothelial cancer.

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer.

For years, breast cancer treatment has been guided by genetic alterations found in tumor tissue, typically through invasive biopsies.

Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, ...

Due to a lack of noticeable symptoms in its early stages and the pancreas’ obscure location behind other organs in the ...